BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3574772)

  • 21. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic comparison of [125I]LSD-labeled 5-HT2A receptor distribution in rat and guinea pig brain.
    Watts SW; Gackenheimer SL; Gehlert DR; Cohen ML
    Neurochem Int; 1994 Jun; 24(6):565-74. PubMed ID: 7981639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 125I-LSD: a high sensitivity ligand for serotonin receptors.
    Hartig PR; Kadan MJ; Evans MJ; Krohn AM
    Eur J Pharmacol; 1983 May; 89(3-4):321-2. PubMed ID: 6873167
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof.
    Mikuni M; Meltzer HY
    Life Sci; 1984 Jan; 34(1):87-92. PubMed ID: 6694512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
    Elliott JM; Kent A
    J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region.
    Altar CA; Boyar WC; Marien MR
    Brain Res; 1986 Apr; 372(1):130-6. PubMed ID: 2423187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of alpha 1-adrenoceptors and 5-HT2 receptors in serotonin-induced contraction of rat prostate: autoradiographical and functional studies.
    Killam AL; Watts SW; Cohen ML
    Eur J Pharmacol; 1995 Jan; 273(1-2):7-14. PubMed ID: 7737320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB
    Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain.
    Subhash MN; Jagadeesh S
    Neurochem Res; 1997 Sep; 22(9):1095-9. PubMed ID: 9251098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding and function of serotonin 2 receptors following chronic administration of imipramine.
    McDonald D; Stancel GM; Enna SJ
    Neuropharmacology; 1984 Nov; 23(11):1265-9. PubMed ID: 6098843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
    Siegel BW; Freedman J; Vaal MJ; Baron BM
    Eur J Pharmacol; 1996 Feb; 296(3):307-18. PubMed ID: 8904083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
    Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
    Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.
    Meibach RC; Maayani S; Green JP
    Eur J Pharmacol; 1980 Oct; 67(4):371-82. PubMed ID: 7449822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells.
    Yagaloff KA; Hartig PR
    J Neurosci; 1985 Dec; 5(12):3178-83. PubMed ID: 4078623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
    Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
    J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.